| 标题 |
Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3 Dual-Targeting Radioligand 177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas |
| 网址 | |
| DOI |
10.2967/jnumed.126.272007
doi
|
| 其它 |
期刊:Journal of Nuclear Medicine 作者:Jialin Xiang; Xuejun Wen; Rongxi Wang; Jiarou Wang; Xingtong Peng; et al 出版日期:2026-08-20 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)